Absent GLUT1 inhibitors approved for human use, we found that the combination treatment of a KD diet and DBI-2 significantly inhibited tumor growth, although admittedly the effect was less than that of the DBI-2 and BAY-876 combination. The gene discussed is SLC2A1; the disease is neoplasm.